home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Eloxx Pharmaceuticals, Inc. - Common Stock (NQ:ELOX)

18.77 +0.32 (+1.76%)

Streaming Delayed Price Updated: 12:51 PM EDT, Aug 4, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Eloxx Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

Why Eloxx Pharmaceuticals (ELOX) Stock Is Soaring Tuesday ↗

July 11, 2023

Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) shares are rocketing higher on Tuesday after Oppenheimer raised its price target from $50 to $55.

Via Benzinga

Eloxx Pharmaceuticals Announces Publication Demonstrating the Power of its TURBO-ZM™ Platform to Target the Human Ribosome for Therapeutic Benefit

July 10, 2023

From Eloxx Pharmaceuticals

Via GlobeNewswire

Eloxx Pharmaceuticals Key Opinion Leader Event Highlights Significant Unmet Need in Treatment of Alport Syndrome Patients with Nonsense Mutations and Additional Positive Results from Phase 2 Clinical Study Evaluating ELX-02

June 28, 2023

From Eloxx Pharmaceuticals

Via GlobeNewswire

Eloxx Pharmaceuticals to Host Investor and Analyst Call on Alport Syndrome

June 21, 2023

From Eloxx Pharmaceuticals

Via GlobeNewswire

Eloxx Pharmaceuticals Plans To Take ELX-02 Into Pivotal Trial For Alport Syndrome ↗

May 24, 2023

Via Benzinga

Recap: Eloxx Pharmaceuticals Q1 Earnings ↗

May 15, 2023

Via Benzinga

Eloxx Pharmaceuticals Highlights Recent Alport Syndrome Natural History Data Presented at 60th ERA Congress

June 21, 2023

From Eloxx Pharmaceuticals

Via GlobeNewswire

Final Data Report: Eloxx Touts Improved Lung Function For Cystic Fibrosis Candidate ↗

June 15, 2023

Eloxx Pharmaceuticals Inc (NASDAQ: ELOX) announced the final data assessment from the Phase 2 trial of ELX-02, the company's lead invest

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

June 08, 2023

Via Benzinga

Eloxx Pharmaceuticals Granted Extension by Nasdaq to Regain Compliance with the Market Value of Listed Securities Continued Listing Requirement

June 06, 2023

Company continuing to prepare for advancement of clinical assets, including ELX-02 pivotal study in Alport Syndrome and ZKN-013 Phase 1 study

From Eloxx Pharmaceuticals

Via GlobeNewswire

Eloxx Pharmaceuticals Intends to Advance ELX-02 into Pivotal Trial for the Treatment of Alport Syndrome with Nonsense Mutations Following Achievement of Remission in Patient in Phase 2 Study

May 24, 2023

From Eloxx Pharmaceuticals

Via GlobeNewswire

Gold Down 1.5%; Baidu Earnings Top Estimates ↗

May 16, 2023

U.S. stocks traded mostly lower toward the end of trading, with the Dow Jones dropping over 250 points on Tuesday. The Dow traded down 0.81% to 33,079.77 while the NASDAQ rose 0.11% to 12,378.50. The...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

May 16, 2023

Via Benzinga

Nasdaq Edges Higher; Home Depot Posts Downbeat Sales ↗

May 16, 2023

U.S. stocks traded mixed midway through trading, with the Nasdaq Composite turning higher on Tuesday. The Dow traded down 0.58% to 33,155.20 while the NASDAQ rose 0.24% to 12,394.69. The S&P 500, also...

Via Benzinga

Why RH Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

May 16, 2023

Gainers GD Culture Group Limited (NASDAQ: GDC) shares climbed 121.9% to $9.63 after gaining over 8% on Monday. GD Culture recently announced an $11.55 million registered direct offering.

Via Benzinga

Why Is Troika (TRKA) Stock Up 31% Today? ↗

May 16, 2023

Troika Media (TRKA) stock is rising higher on Tuesday after the release of its earnings report for the first quarter of 2023.

Via InvestorPlace

Why Is Tivic Health Systems (TIVC) Stock Down 28% Today? ↗

May 16, 2023

Tivic Health Systems (TIVC) stock is sliding lower on Tuesday after the company released its earnings report for the first quarter of 2023.

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

May 16, 2023

Via Benzinga

Why Is Eloxx Pharmaceuticals (ELOX) Stock Down 27% Today? ↗

May 16, 2023

Eloxx Pharmaceuticals (ELOX) stock is falling hard on Tuesday after the company provided a weak earnings report for Q1 2023.

Via InvestorPlace

Why VirTra Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket ↗

May 16, 2023

Gainers VivoPower International PLC (NASDAQ: VVPR) shares surged 88.3% to $0.8701 in pre-market trading as the company reported a definitive distribution agreement to distribute EV fleet charging...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

May 16, 2023

It's time to start off the day with a breakdown of all the biggest pre-market stock movers worth keeping an eye on Tuesday!

Via InvestorPlace

Tesla, C3.ai, Rumble, Eloxx, Nu: Why These 5 Stocks Are Drawing Investor Attention Today ↗

May 15, 2023

Via Benzinga

Eloxx Pharmaceuticals Reports First Quarter 2023 Financial and Operating Results and Provides Business Update

May 15, 2023

From Eloxx Pharmaceuticals

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's Intraday Session ↗

May 15, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

May 05, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

May 02, 2023

Via Benzinga

Eloxx Pharmaceuticals Announces FDA Clearance to Begin Single Ascending Dose Study of ZKN-013

May 02, 2023

From Eloxx Pharmaceuticals

Via GlobeNewswire

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

April 13, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

April 10, 2023

Via Benzinga

Stocks Choppy Amid Renewed Recession Buzz ↗

April 10, 2023

The Dow Jones Industrial Average is flat midday but has brushed off steep premarket losses, as investors weigh looming recession concerns.

Via Talk Markets

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com